We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 43

Apotex Inc. v. Pfizer Ireland Pharmaceuticals (2010 FC 968)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Apotex appealed an Order of Prothonotary Aalto dismissing a motion to strike parts of Pfizer’s Statement of Defence relating to res judicata, estoppel (issue and collateral), comity and abuse of process

Novopharm Limited v. Pfizer Canada inc. (2010 FCA 242)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Novopharm appealed the decision of the Federal Court to grant an order of prohibition to Pfizer in respect of Novopharm’s generic version of VIAGRA

Eli Lilly Canada inc. v. Apotex Inc. (2010 FC 952)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Apotex brought a motion to set aside an Order from 2007 granting Eli Lilly’s applications for a prohibition Order in PMNOC proceedings

Novopharm Limited v. Eli Lilly and Company (2010 FC 915)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

An impeachment action was brought by Novopharm in respect of a patent for STRATTERA alleging obviousness, anticipation, utility and improper selection

Merck-Frosst-Schering Pharma GP v. Canada (Health) (2010 FC 933)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Merck-Frosst (“Merck”) applied for an order prohibiting the Minister of Health from issuing a Notice of Compliance to Teva for its generic version of Ezetimibe

Epicept Corporation v. Canada (Health) (2010 FC 956)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

The Minister of Health refused to grant data exclusivity to data from Epicept’s phase I and phase II clinical trials because CEPLENE is not an “innovative drug”

Eli Lilly Canada Inc. v. Apotex Inc (2010 FCA 240)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

This was an appeal of the decision of Madame Justice Gauthier (in the Federal Court) who had found that although Lilly met its burden to prove that Apotex infringed eight Lilly process patents related to the manufacture of the antibiotic cefaclor for material imported before June 3, 1998, Lilly failed to do so for the cefaclor imported into Canada after June 3, 1998

Apotex Inc. v. Shire Canada Inc. (2010 FC 1001)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Shire appealed the Order of Prothonotary Tabib denying it permission to amend, in part, its Statement of Defence

Apotex v Lundbeck, motion to strike pleadings and for security for costs, escitalopram, August 5, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 21 2010

In earlier PMNOC proceedings, Lundbeck successfully obtained an order prohibiting the Minister from issuing a Notice of Compliance to Apotex in respect of its escitalopram product

Apotex v. Janssen-Ortho, motion to vary order of Federal Court of Appeal, levofloxacin, August 20, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 21 2010

Apotex filed a Notice of Allegation alleging that a particular patent licensed by Janssen-Ortho was invalid and not infringed